A citation-based method for searching scientific literature

Stefano Vavassori, Jacob D Galson, Johannes Trück, Anke van den Berg, Rienk Y J Tamminga, Aude Magerus-Chatinet, Olivier Pellé, Ulrike Camenisch Gross, Ewerton Marques Maggio, Seraina Prader, Lennart Opitz, Ursina Nüesch, Andrea Mauracher, Benjamin Volkmer, Oliver Speer, Luzia Suda, Benno Röthlisberger, Dieter Robert Zimmermann, Rouven Müller, Arjan Diepstra, Lydia Visser, Eugenia Haralambieva, Bénédicte Neven, Frédéric Rieux-Laucat, Jana Pachlopnik Schmid. Blood Adv 2017
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity.
Jack Hutcheson, John C Scatizzi, Akbar M Siddiqui, G Kenneth Haines, Tianfu Wu, Quan-Zhen Li, Laurie S Davis, Chandra Mohan, Harris Perlman. Immunity 2008
159
50

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.
Joao B Oliveira, Jack J Bleesing, Umberto Dianzani, Thomas A Fleisher, Elaine S Jaffe, Michael J Lenardo, Frederic Rieux-Laucat, Richard M Siegel, Helen C Su, David T Teachey,[...]. Blood 2010
268
50

Juvenile myelomonocytic leukemia.
Prakash Satwani, Justine Kahn, Christopher C Dvorak. Pediatr Clin North Am 2015
9
50


Immune modulation by Fas ligand reverse signaling: lymphocyte proliferation is attenuated by the intracellular Fas ligand domain.
Katharina Lückerath, Vladimir Kirkin, Inga Maria Melzer, Frederic B Thalheimer, Dagmar Siele, Wiebke Milani, Thure Adler, Antonio Aguilar-Pimentel, Marion Horsch, Geert Michel,[...]. Blood 2011
19
50

Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.
N Holler, R Zaru, O Micheau, M Thome, A Attinger, S Valitutti, J L Bodmer, P Schneider, B Seed, J Tschopp. Nat Immunol 2000
50

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.
Kennichi C Dowdell, Julie E Niemela, Susan Price, Joie Davis, Ronald L Hornung, João Bosco Oliveira, Jennifer M Puck, Elaine S Jaffe, Stefania Pittaluga, Jeffrey I Cohen,[...]. Blood 2010
81
50


Autoimmune lymphoproliferative syndrome: an update and review of the literature.
Shaili Shah, Eveline Wu, V Koneti Rao, Teresa K Tarrant. Curr Allergy Asthma Rep 2014
46
50

Immune disorders caused by defects in the caspase cascade.
Jennifer M Puck, Shigui Zhu. Curr Allergy Asthma Rep 2003
6
50

Clinical, immunological, and pathological consequences of Fas-deficient conditions.
F Le Deist, J F Emile, F Rieux-Laucat, M Benkerrou, I Roberts, N Brousse, A Fischer. Lancet 1996
154
50

Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.
Anne Rensing-Ehl, Simon Völkl, Carsten Speckmann, Myriam Ricarda Lorenz, Julia Ritter, Ales Janda, Mario Abinun, Hanspeter Pircher, Bertram Bengsch, Robert Thimme,[...]. Blood 2014
35
50

CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone Mice.
Amanda Poissonnier, Doriane Sanséau, Matthieu Le Gallo, Marine Malleter, Nicolas Levoin, Roselyne Viel, Lucie Morere, Aubin Penna, Patrick Blanco, Alain Dupuy,[...]. Immunity 2016
56
50


Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
Hyung J Chun, Lixin Zheng, Manzoor Ahmad, Jin Wang, Christina K Speirs, Richard M Siegel, Janet K Dale, Jennifer Puck, Joie Davis, Craig G Hall,[...]. Nature 2002
503
50

Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.
Lilia L Bi, George Pan, T Prescott Atkinson, Lixin Zheng, Janet K Dale, Christopher Makris, Vishnu Reddy, Jay M McDonald, Richard M Siegel, Jennifer M Puck,[...]. BMC Med Genet 2007
50
50

Caspase-8 Deficiency Presenting as Late-Onset Multi-Organ Lymphocytic Infiltration with Granulomas in two Adult Siblings.
Julie Niemela, Hye Sun Kuehn, Corin Kelly, Mingchang Zhang, Joie Davies, Jose Melendez, Jennifer Dreiling, David Kleiner, Katherine Calvo, João B Oliveira,[...]. J Clin Immunol 2015
19
50

Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.
Masatoshi Takagi, Kunihiro Shinoda, Jinhua Piao, Noriko Mitsuiki, Mari Takagi, Kazuyuki Matsuda, Hideki Muramatsu, Sayoko Doisaki, Masayuki Nagasawa, Tomohiro Morio,[...]. Blood 2011
87
50

The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical features and long-term follow-up in 31 patients.
Maria Francesca Campagnoli, Letizia Garbarini, Paola Quarello, Emanuela Garelli, Adriana Carando, Valentina Baravalle, Alessandra Doria, Alessandra Biava, Annalisa Chiocchetti, Angelo Rosolen,[...]. Haematologica 2006
36
50

Molecular basis of juvenile myelomonocytic leukemia.
Andrica C H de Vries, C Michael Zwaan, Marry M van den Heuvel-Eibrink. Haematologica 2010
37
50

A role for CD95 ligand in preventing graft rejection.
D Bellgrau, D Gold, H Selawry, J Moore, A Franzusoff, R C Duke. Nature 1995
50

Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis.
Julie E Niemela, Lianghao Lu, Thomas A Fleisher, Joie Davis, Iusta Caminha, Marc Natter, Laurel A Beer, Kennichi C Dowdell, Stefania Pittaluga, Mark Raffeld,[...]. Blood 2011
87
50

A novel homozygous Fas ligand mutation leads to early protein truncation, abrogation of death receptor and reverse signaling and a severe form of the autoimmune lymphoproliferative syndrome.
Schafiq Nabhani, Andrea Hönscheid, Prasad T Oommen, Bernhard Fleckenstein, Jörg Schaper, Michaela Kuhlen, Hans-Jürgen Laws, Arndt Borkhardt, Ute Fischer. Clin Immunol 2014
17
50


Juvenile myelomonocytic leukemia and Noonan syndrome.
K Choong, M H Freedman, D Chitayat, E N Kelly, G Taylor, A Zipursky. J Pediatr Hematol Oncol 1999
99
50

Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.
Franco Locatelli, Mattia Algeri, Pietro Merli, Luisa Strocchio. Expert Rev Hematol 2018
15
50

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Eliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, Peter D Arkwright, Françoise Selz, Anne-Marie Prieur, Stéphane Blanche, Jirina Bartunkova, Etienne Vilmer, Alain Fischer,[...]. N Engl J Med 2004
202
50

Autoimmune disease and multiple autoantibodies in 42 patients with RASopathies.
Caio R D C Quaio, Jozélio F Carvalho, Clovis A da Silva, Cleonice Bueno, Amanda S Brasil, Alexandre C Pereira, Alexander A L Jorge, Alexsandra C Malaquias, Chong A Kim, Débora R Bertola. Am J Med Genet A 2012
49
50

Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome.
Elisa Cerutti, Maria F Campagnoli, Massimo Ferretti, Emanuela Garelli, Nicoletta Crescenzio, Angelo Rosolen, Annalisa Chiocchetti, Michael J Lenardo, Ugo Ramenghi, Umberto Dianzani. BMC Immunol 2007
27
50

Caspase-10 Negatively Regulates Caspase-8-Mediated Cell Death, Switching the Response to CD95L in Favor of NF-κB Activation and Cell Survival.
Sebastian Horn, Michelle A Hughes, Ramon Schilling, Carsten Sticht, Tencho Tenev, Michaela Ploesser, Pascal Meier, Martin R Sprick, Marion MacFarlane, Martin Leverkus. Cell Rep 2017
64
50

Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.
Aude Magerus-Chatinet, Bénédicte Neven, Marie-Claude Stolzenberg, Cécile Daussy, Peter D Arkwright, Nina Lanzarotti, Catherine Schaffner, Sophie Cluet-Dennetiere, Filomeen Haerynck, Gérard Michel,[...]. J Clin Invest 2011
81
50

Structural principles of tumor necrosis factor superfamily signaling.
Éva S Vanamee, Denise L Faustman. Sci Signal 2018
129
50


Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network.
Aurélie Caye, Marion Strullu, Fabien Guidez, Bruno Cassinat, Steven Gazal, Odile Fenneteau, Elodie Lainey, Kazem Nouri, Saeideh Nakhaei-Rad, Radovan Dvorsky,[...]. Nat Genet 2015
110
50

Juvenile myelomonocytic leukemia-associated variants are associated with neo-natal lethal Noonan syndrome.
Heather Mason-Suares, Diana Toledo, Jean Gekas, Katherine A Lafferty, Naomi Meeks, M Cristina Pacheco, David Sharpe, Thomas E Mullen, Matthew S Lebo. Eur J Hum Genet 2017
9
50

Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.
A Bettinardi, D Brugnoni, E Quiròs-Roldan, A Malagoli, S La Grutta, A Correra, L D Notarangelo. Blood 1997
157
50

Constitutional trisomy 8p11.21-q11.21 mosaicism: a germline alteration predisposing to myeloid leukaemia.
Tim Ripperger, Marcel Tauscher, Inka Praulich, Brigitte Pabst, Andrea Teigler-Schlegel, Allen Yeoh, Gudrun Göhring, Brigitte Schlegelberger, Christian Flotho, Charlotte M Niemeyer,[...]. Br J Haematol 2011
20
50

Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes.
C P Kratz, L Franke, H Peters, N Kohlschmidt, B Kazmierczak, U Finckh, A Bier, B Eichhorn, C Blank, C Kraus,[...]. Br J Cancer 2015
119
50

Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity.
Peter D Hughes, Gabrielle T Belz, Karen A Fortner, Ralph C Budd, Andreas Strasser, Philippe Bouillet. Immunity 2008
188
50

Occurrence of myeloproliferative disorder in patients with Noonan syndrome.
B Bader-Meunier, G Tchernia, F Miélot, J L Fontaine, C Thomas, S Lyonnet, J M Lavergne, J P Dommergues. J Pediatr 1997
126
50

The importance of considering monogenic causes of autoimmunity: A somatic mutation in KRAS causing pediatric Rosai-Dorfman syndrome and systemic lupus erythematosus.
Robert J Ragotte, Anita Dhanrajani, Julian Pleydell-Pearce, Kate L Del Bel, Maja Tarailo-Graovac, Clara van Karnebeek, Jefferson Terry, Christof Senger, Margaret L McKinnon, Michael Seear,[...]. Clin Immunol 2017
31
50

Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele.
Saoussen Karray, Chantal Kress, Sylvain Cuvellier, Catherine Hue-Beauvais, Diane Damotte, Charles Babinet, Matthieu Lévi-Strauss. J Immunol 2004
55
50

MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment.
Pier Paolo Leoncini, Alice Bertaina, Dimitrios Papaioannou, Christian Flotho, Riccardo Masetti, Silvia Bresolin, Giuseppe Menna, Nicola Santoro, Marco Zecca, Giuseppe Basso,[...]. Oncotarget 2016
26
50

Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction.
Ashley E Weant, Ryan D Michalek, Islam U Khan, Beth C Holbrook, Mark C Willingham, Jason M Grayson. Immunity 2008
150
50

The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways.
T Kataoka, R C Budd, N Holler, M Thome, F Martinon, M Irmler, K Burns, M Hahne, N Kennedy, M Kovacsovics,[...]. Curr Biol 2000
473
50

NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
João B Oliveira, Nicolas Bidère, Julie E Niemela, Lixin Zheng, Keiko Sakai, Cynthia P Nix, Robert L Danner, Jennifer Barb, Peter J Munson, Jennifer M Puck,[...]. Proc Natl Acad Sci U S A 2007
151
50

Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.
Hirotoshi Sakaguchi, Yusuke Okuno, Hideki Muramatsu, Kenichi Yoshida, Yuichi Shiraishi, Mariko Takahashi, Ayana Kon, Masashi Sanada, Kenichi Chiba, Hiroko Tanaka,[...]. Nat Genet 2013
165
50

Whole-exome-sequencing-based discovery of human FADD deficiency.
Alexandre Bolze, Minji Byun, David McDonald, Neil V Morgan, Avinash Abhyankar, Lakshmanane Premkumar, Anne Puel, Chris M Bacon, Frédéric Rieux-Laucat, Ki Pang,[...]. Am J Hum Genet 2010
123
50

A quantitative measurement of the human somatic mutation rate.
David J Araten, David W Golde, Rong H Zhang, Howard T Thaler, Lucia Gargiulo, Rosario Notaro, Lucio Luzzatto. Cancer Res 2005
114
50

Autoimmune lymphoproliferative syndrome caused by a homozygous FasL mutation that disrupts FasL assembly.
Ali Sobh, Elena Crestani, Brittney Cangemi, Jennifer Kane, Janet Chou, Sung-Yun Pai, Luigi D Notarangelo, Waleed Al-Herz, Raif S Geha, Michel J Massaad. J Allergy Clin Immunol 2016
7
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.